Endometrial Ablation Market Share, Size, Trends, Industry Analysis Report, By Type (Devices {Cryoablation, Radiofrequency Ablation, Hydrothermal Ablation, Thermal Balloon, Microwave Energy, Hysteroscopy}, Procedures); By End Use; By Region; Segment Forecast, 2022 - 2030
- Published Date:Jan-2022
- Pages: 111
- Format: PDF
- Report ID: PM2155
- Base Year: 2021
- Historical Data: 2018 - 2020
Report Outlook
The global endometrial ablation market was valued at USD 3.26 billion in 2021 and is expected to grow at a CAGR of 5.6% during the forecast period. The demand for endometrial ablation is rising owing to the growing number of females suffering from gynecological disorders, menorrhagia, and cervical cancer is accelerating the market demand globally.
Know more about this report: request for sample pages
Besides, rising responsiveness for the endometrial ablation as well as the availability of technologically developed devices is attributed to the market demand. Furthermore, the endometrial removal devices offer several benefits such as effectiveness, a lower rate of site effectiveness, rapid treatment, and post-surgery hospitalization, which, in turn, may act as a catalyzing factor for the endometrial ablation market growth.
The outbreak of COVIID-19 has affected every sector of the global economy including the endometrial ablation market. The various services across the healthcare sector were classified as not-obligatory, insignificant, and outpatient interventional procedures were restricted or bunged during the widespread of the coronavirus. The disruption in the supply chain and logistics, as well as growing concern regarding the spread of the virus, may slightly hamper the number of hospitals visits by the patients.
However, the endometrial ablation market is projected to grow because the extended wait times may increase the chances of mortality as well as requires more complex surgeries later. Hence, these factors may globally boost the demand for endometrial removal procedures in the near future.
Know more about this report: request for sample pages
Industry Dynamics
Growth Drivers
The concern for women's health is growing across the globe, for which various governments are taking initiatives that may drive the segment growth. In reproductive-aged women, Abnormal Uterine Bleeding (AUB) is the most common disorder. AUB leads to loss of fertility and may require surgical intervention. According to the National Health Portal India, amid menarche and menopause, AUB is likely to affect 9% to 14% of women. The commonness of target disease differs from country to country. The occurrence of AUB has been projected to be about 17.9% in India. Thereby, these factors may demand appropriate healthcare procedures for the treatment, which, in turn, may boost the growth of the market.
Moreover, one of the major basics anticipated to drive the industry in developed nations is women's coverage plans. For instance, in India, tax exemptions for women and favorable government policies to claim on the payments intended for health insurance policies. These types of initiatives with respect to women’s health are likely to lead to the adoption of treatment alternatives available for them to contribute to the endometrial removal surgical procedure. Hence, these factors act as catalyzing factors for the global industry growth in the impending years.
Report Segmentation
The market is primarily segmented on the basis of type, end-use, and region.
|
By Type |
By End-Use |
By Region |
|
|
|
Know more about this report: request for sample pages
Insight by Technology
The devices segment was the leading segment in terms of revenue generation in 2021. The availability of several effective techniques and devices where abnormal tissues are frozen and smashed by utilizing an exceedingly cold fluid or a device known as a cryoprobe; radiofrequency ablation in which high-energy radio waves are opting for destroying the endometrial tissue; and balloon therapy, in which endometrium is shattered by injecting heated fluid inside the balloon.
Besides, benefits such as efficacy, product convenience, faster treatment, and economical compared to further endometrial removal devices are majorly attributed to the segment demand. Furthermore, the easy accessibility of the endometrial removal devices among physicians is also acting as a catalyzing factor for the market segment growth in the near future.
The procedure segment is the second dominating segment in the global market. Endometrial ablation is a procedure for decreasing severe menstrual bleeding by obliterating the endometrium, which is a thin layer of tissue that lines the uterus. The incidences of menorrhagia in women are increasing, which is fueling the segment growth. Factors such as treatment effectiveness and rising awareness regarding the availability of the treatment are accelerating the segment growth across the globe.
Insight by End-Use
The hospital segment is accounted for the highest revenue shares in the global market and is expected to rise in the approaching years. Hospitals offer proper care and reimbursements, which attributes to segment dominance. Besides, hospitals possess advanced treatment devices along with ease of managing any further problems that may occur during surgical procedures is lead to a positive influence on the segment growth. Moreover, the higher inflow of patients for gynecological treatments as well as the availability of a wide range of treatment options may foster the segment demand around the world.
The Ambulatory Surgery Center (ASC) segment is holding is likely to grow at the highest CAGR in the global endometrial ablation industry over the forthcoming scenario. These healthcare settings provide several personalized treatments, cost-effective services, and a well-suitable environment, which contributes towards the segment demand. Furthermore, ASCs have no or minimum chances of spreading Hospital-Acquired Infections (HAIs), minimal waiting time, and small stay duration after treatment. Hence, these factors are projected to show the increasing demand for these facilities in the forthcoming scenario.
Geographic Overview
Geographically, North America is the largest contributor of revenue in 2021 and is expected to dominate the global market in the forecasting period. Factors such as enhancement in healthcare infrastructure, increasing awareness for availability of treatments regarding gynecological disorders, as well as a strong foundation of key market competitors for delivering cutting-edge endometrial removal devices is accelerating the segment demand. Likewise, higher healthcare spending, the establishment of numerous projects to improve healthcare quality, and offering the least price benefits to end-users may further lead to the demand for the endometrial ablation market. Therefore, these factors are propelling the market growth across North America.
Moreover, Asia Pacific is projected to grow at the highest CAGR across the globe in the approaching years. The demand for innovative and technological endometrial ablation devices is growing along with the increase in the prevalence of menorrhagia owing to the poor standards of hygiene is impelling the segment growth. Besides, supportive government policies coupled with rising investment in the healthcare sector, rising awareness related to abnormal uterine bleeding, and growing responsiveness for minimally invasive procedures may create lucrative opportunities for the segment in the approaching years.
Competitive Insight
Some of the major players operating in the global market include AngioDynamics, Boston Scientific Corp, CooperSurgical Inc., Ethicon, Inc. (Johnson & Johnson), Hologic, Inc., Medtronic, Minerva Surgical, Inc., Olympus Corp., and Richard Wolf GmbH.
Endometrial Ablation Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2021 |
USD 3.26 billion |
|
Revenue forecast in 2030 |
USD 5.28 billion |
|
CAGR |
5.6% from 2022 - 2030 |
|
Base year |
2021 |
|
Historical data |
2018 - 2020 |
|
Forecast period |
2022 - 2030 |
|
Quantitative units |
Revenue in USD million/billion and CAGR from 2022 to 2030 |
|
Segments covered |
By Type, By End-Use, By Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
|
Key companies |
AngioDynamics, Boston Scientific Corp, CooperSurgical Inc., Ethicon, Inc. (Johnson & Johnson), Hologic, Inc., Medtronic, Minerva Surgical, Inc., Olympus Corp., and Richard Wolf GmbH. |
© 2024 Polaris Market Research and Consulting. All rights reserved
